199 related articles for article (PubMed ID: 7392308)
41. [Investigation of 99mTc-diphosphonate scintigraphy in patients with lung, breast or prostatic cancer (author's transl)].
Tonami N; Ueno K; Sugihara M; Michigishi T; Aburano T
Kaku Igaku; 1977 Aug; 14(4):493-500. PubMed ID: 926447
[No Abstract] [Full Text] [Related]
42. [99mTc-methylene diphosphonate for skeletal imaging (author's transl)].
Yatomi K; Nakasikiryo K; Okada R; Ogasawara M; Nakagawa T; Nakagawa K; Kinoshita F
Radioisotopes; 1977 Nov; 26(11):810-2. PubMed ID: 202999
[No Abstract] [Full Text] [Related]
43. [Investigation of 99mTc-methylene diphosphonate scintigraphy of patients with lung cancer].
Abe M; Ohde R; Ogata T; Kawaguchi S; Kikuchi K; Kawai T; Matsuzawa K; Takanoshi H
Rinsho Hoshasen; 1982 Jun; 27(6):621-5. PubMed ID: 6292553
[No Abstract] [Full Text] [Related]
44. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)].
Ishii C; Mori Y; Hata Y; Katsuyama N; Fujioka M; Fukazawa W; Hashimoto H; Horiuchi T; Fujioka M; Kawakami K
Radioisotopes; 1981 Jul; 30(7):401-3. PubMed ID: 7323328
[No Abstract] [Full Text] [Related]
45. [Fundamental and clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)].
Oshiro N; Bito S; Ito H; Morimoto Y; Ikekubo K; Ishihara T; Mori T
Kaku Igaku; 1982 Mar; 19(2):305-11. PubMed ID: 6213802
[No Abstract] [Full Text] [Related]
46. [Bone scintigraphy in prostatic cancer. Correlation with clinical and laboratory features and with survival].
Lobo G; Ladrón de Guevara D; Salgado G; Donoso G; Bagus F
Rev Med Chil; 1999 Feb; 127(2):181-8. PubMed ID: 10436698
[TBL] [Abstract][Full Text] [Related]
47. [Clinical studies on the detection of bone metastasis in lung cancer by bone scintigraphy].
Nakano S; Hasegawa Y; Kajita A; Nakamura S; Horai T; Ikegami H; Matuda M; Okamoto N; Nabeshima H; Doi O; Komatubara Y; Ishigami S
Kaku Igaku; 1983 Feb; 20(1):37-43. PubMed ID: 6308314
[No Abstract] [Full Text] [Related]
48. [Basic and clinical studies on bone deposition of 99mTc-labeled hydroxymethylene diphosphonate: a comparison with 99mTc-methylene diphosphonate (author's transl)].
Muranaka A; Ito Y; Otsuka N; Nagai K; Terashima H; Yanagimoto S; Kaji T; Nakano Y; Hayashi M; Hazue M
Kaku Igaku; 1981 Mar; 18(2):273-81. PubMed ID: 6454802
[No Abstract] [Full Text] [Related]
49. [6. Quantitative Evaluation of the Bone Scintigraphy in the Prostate Cancer].
Yamamoto Y
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2017; 73(10):1087-1094. PubMed ID: 29057782
[No Abstract] [Full Text] [Related]
50. [Clinical evaluation of bone scintigraphy with 99mTc-labeled phosphate compounds (part three)--metabolic bone diseases and bone dysplasias-- (author's transl)].
Yamamoto I
Kaku Igaku; 1978 Dec; 15(8):1111-24. PubMed ID: 748646
[No Abstract] [Full Text] [Related]
51. [Clinical study of skeletal scan using 99mTc-methylene diphosphonate (author's transl)].
Sasaki T; Ohno A; Matsubara K; Kobayashi H; Mashita S; Kaii O; Mishima A; Kato K; Yamaguchi H
Radioisotopes; 1977 Dec; 26(12):885-7. PubMed ID: 605228
[No Abstract] [Full Text] [Related]
52. Bony expansion in skeletal metastases from carcinoma of the prostate as seen by bone scintigraphy.
Resnik CS; Garver P; Resnick D
South Med J; 1984 Oct; 77(10):1331-5. PubMed ID: 6484659
[TBL] [Abstract][Full Text] [Related]
53. Quantitative bone scintigraphy: usefulness in the survey of patients treated for bone metastasis of prostatic cancer.
Grob JC; Lallot C; Methlin G; Bollack C
Eur Urol; 1988; 15(3-4):193-5. PubMed ID: 3145888
[TBL] [Abstract][Full Text] [Related]
54. [Detection of metastatic bone tumors by radionuclide imaging (author's transl)].
Uchiyama G; Uno K; Umeda T; Nagase J
Rinsho Hoshasen; 1979 Jul; 24(7):747-54. PubMed ID: 480669
[No Abstract] [Full Text] [Related]
55. [Basic and clinical studies on bone deposition of 99mTc-labeled methylene diphosphonate (author's transl)].
Ito Y; Muranaka A; Otsuka M; Uchida M; Kajihara Y
Radioisotopes; 1977 Jun; 26(6):382-8. PubMed ID: 578955
[No Abstract] [Full Text] [Related]
56. [Diagnosis of neuroblastoma by RI scintigraphy (author's transl)].
Sugihara M; Suzuki Y
Rinsho Hoshasen; 1980; 25(6):703-4. PubMed ID: 7401352
[No Abstract] [Full Text] [Related]
57. [Intraoperative localization of metastases with a hand-held gamma probe].
Adams S; Hovy L; Baum RP; Adams M; Maul FD; Kahla-Witzsch H; Zichner L; Jonas D; Hör G
Nuklearmedizin; 1995 Aug; 34(4):161-4. PubMed ID: 7675647
[TBL] [Abstract][Full Text] [Related]
58. Which metabolic imaging, besides bone scan with 99mTc-phosphonates, for detecting and evaluating bone metastases in prostatic cancer patients? An open discussion.
Bombardieri E; Setti L; Kirienko M; Antunovic L; Guglielmo P; Ciocia G
Q J Nucl Med Mol Imaging; 2015 Dec; 59(4):381-99. PubMed ID: 26337240
[TBL] [Abstract][Full Text] [Related]
59. [Extraosseous tumor uptake of 99m technetium methylendiphosphonate in children with neuroblastoma (author's transl)].
Mancini AF; Turba E; Vallicelli R; Vitelli A; Fini A; Rosito P
Pediatr Med Chir; 1981; 3(6):535-9. PubMed ID: 6211661
[No Abstract] [Full Text] [Related]
60. [Fundamental and clinical investigation on the bone scintigraphy using 99mTc-methylenediphosphonate (author's transl)].
Dokoh S; Morita R; Yamamoto I; Fukunaga M; Fujita T; Saji H; Torizuka K
Kaku Igaku; 1978 Apr; 15(2):261-6. PubMed ID: 671867
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
